Developing oligonucleotide therapeutics for human leukemia

Anti-Cancer Drug Design

Volumn 12, Issue 5, 1997, Pages 341-358

  Gewirtz, Alan M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE;

GENE DISRUPTION; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; LEUKEMIA; LEUKEMIA CELL; ONCOGENE C MYB; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW;

ANIMALS; HUMANS; LEUKEMIA; OLIGONUCLEOTIDES, ANTISENSE; ONCOGENES;

EID: 0030761580     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. ANFOSSI, G., GEWIRTZ, A.M. & CALABRETTA, B. (1989). An oligomer complementary to c-Myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proceedings of the National Academy of Sciences, USA, 86, 3379.
2. BARLETTA, C., PELICCI, P.G., KENYOK L C , SMITH, S.D. & DALLA-FAVERA, R. (1987). Relationship between the c-Myb locus and the 6q-chromosomal aberration in leukemias and lymphomas. Science, 235, 1064.
3. BASKERVILLE, S. & ELLINGTON, A.D. (1995). RNA structure. Describing the elephant. Current Biology, 5, 120.
4. BELTINGER, C., SARAGOVI, H.U., SMITH, R.M., LESAUTEUR, L., SHAH, N., DEDIONISIO, L., CHRISTENSEN, L., RAIBLE, A., JARETT, L. & GEWIRTZ, A.M (1995). Binding, uptake and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. Journal of Clinical Investigation, 95, 1814.
5. BERGAN, R., HAKIM, F., SCHWARTZ, G.N., KYLE, E., CEPADA, R., SZABO, J.M., FOWLER, D., GRESS, R & NECKERS, L. (1996). Electroporation of synthetic oligodeoxynucleotides: a novel technique for ex vivo bone marrow purging. Blood, 88, 731.
6. BIEDENKAPP, H., BORGMEYER, U., SIPPEL, A.E. & KLEMPNAUER, K.H. (1988). Viral Myb oncogene encodes a sequence-specific DNA-binding activity. Nature, 335, 835.
7. BURK, O., MINK, S., RINGWALD, M & KLEMPNAUER, K.H. (1993). Synergistic activation of the chicken mim-1 gene by v-Myb and C/EBP transcription factors. The EMBO Journal, 12, 2027.
8. CALABRETTA, B., SIMS, R.B., VALTIERI, M., CARACCIOLO, D , SZCZYLIK, C., VENTURELLI, D., RATAJCZAK, M., BERAN, M. & GEWIRTZ, A M. (1991). Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-Myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Proceedings of the National Academy of Sciences, USA, 88, 2351.
9. CARACCIOLO, D., VENTURELLI, D., VALTIERI, M., PESCHLE, C., GEWIRTZ, A.M. & CALABRETTA, B. (1990). Stage-related proliferative activity determines c-Myb functional requirements during normal human hematopoiesis. Journal of Clinical Investigation, 85, 55.
10. CARSON, W.E., BAIOCCHI, R.A., CROCE, C.M. & CALIGIURI, M.A. (1994). The c-kit ligand suppresses apoptosis of human natural killer cells through the upreguation of bcl-2. Proceedings of the National Academy of Sciences, USA, 91, 7553.
11. CLARKE, M.F., KUKOWSKA-LATALLO, J.F., WESTIN, E., SMITH, M. & PROCHOWNIK, E.V. (1988). Constitutive expression of a c-Myb cDNA blocks Friend murine erythroleukemia cell differentiation. Molecular and Cellular Biology, 8, 88.
12. COGSWELL, J.P., COGSWELL, P.C., KUEHL, W.M., CUDDIHY, A.M., BENDER, T.M., ENGELKE, U., MARCU, K.B. & TING, J.P. (1993). Mechanism of c-myc regulation by c-Myb in different cell lineages. Molecular and Cellular Biology, 13, 2858.
13. DINI, P.W., ELTMAN, J.T. & LIPSICK, J.S. (1995). Mutations in the DNA-binding and transcriptional activation domains of v-Myb cooperate in transformation. Journal of Virology, 69, 2515.
14. GALLI-TALIADOROS, L A., SEDGWICK, J.D. WOOD, S.A. & KORNER, H. (1995). Gene knock-out technology: a methodological overview for the interested novice. Journal of Immunological Methods, 181, 1.
15. GEWIRTZ, A.M. & CALABRETTA, B. (1988). A c-Myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science, 242, 1303.
16. GEWIRTZ, A.M., ANFOSSI, G , VENTURELLI, D., VALPREDA, S., SIMS, R. & CALABRETTA, B. (1989) G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-Myb. Science, 245, 180.
17. GEWIRTZ, A.M., LUGER, S., SOKOL, D, GOWDIN, B., STADTMAUER, E , RECCIO, A. & RATAJCZAK, M.Z. (1996a). Oligodeoxynucleotide therapeutics for human myelogenous leukemia: interim results. Blood, 88, 270a.
18. GEWIRTZ, A.M , STEIN, C.A. & GLAZER, P.M. (1996b). Facilitating oligonucleotide delivery: helping antisense deliver on its promise. Proceedings of the National Academy of Sciences, USA, 93, 3161.
19. HEYER, W.D. & KOHLI, J. (1994). Homologous recombination. Experientia, 50, 189.
20. HIJIYA, N., ZHANG, J., RATAJCZAK, M.Z., KANT, J.A., DERIEL, K., HERLYN, M., ZON, G. & GEWIRTZ, A.M. (1994). Biologic and therapeutic significance of MYB expression in human melanoma. Proceedings of the National Academy of Sciences, USA, 91, 4499.
21. KANEI-ISHII, C., MACMILLAN, E.M., NOMURA, T., SARAI, A., RAMSAY, R.G., AIMOTO, S, ISHII, S. & GONDA, T.J. (1992). Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proceedings of the National Academy of Sciences, USA, 89, 3088.
22. KU, D.H., WEN, S.C., ENGELHARD, A., NICOLAIDES, N.C , LIPSON, K.E., MARINO, T A. & CALABRETTA, B. (1993). c-Myb transactivates cdc2 expression via Myb binding sites in the 5′-flanking region of the human cdc2 gene [published erratum appears in Journal of Biological Chemistry, 1993 268, 13010]. Journal of Biological Chemistry, 268, 2255.
23. LEWIS, J.G., LIN, K.Y., KOTHAVALE, A., FLANAGAN, W.M., MATTEUCCI, M D , DEPRINCE, R.B., MOOK, R.A. JR, HENDREN, R.W & WAGNER, R.W. (1996). A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proceedings of the National Academy of Sciences, USA, 93, 3176.
24. LIEBERMANN, D.A. & HOFFMAN-LIEBERMANN, B. (1989). Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade. Oncogene, 4, 583.
25. LOKE, S L, STEIN, C.A , ZHANG, X.H., MORI, K., NAKANISHI, M., SUBASINGHE, C., COHEH J.S. & NECKERS, L.M. (1989). Characterization of oligonucleotide transport into living cells. Proceedings of the National Academy of Sciences, USA, 86, 3474.
26. LUGER, S.M., RATAJCZAK, J , RATAJCZAK, M.Z., KUCZYNSKI, W.I., DIPAOLA, R.S., NGO, W , CLEVENGER, C.V. & GEWIRTZ, A.M (1996). A functional analysis of protooncogene Vav's role in adult human hematopoiesis. Blood, 87, 1326.
27. LYON, J., ROBINSON, C. & WATSON, R. (1994). The role of Myb proteins in normal and neoplastic cell proliferation. Critical Reviews in Oncogenetics, 5, 373.
28. MELOTTI, P., KU, D H & CALABRETTA, B (1994). Regulation of the expression of the hematopoietic stem cell antigen CD34: role of c-Myb. Journal of Experimental Medicine, 179, 1023.
29. METCALF, D (1994). Blood. Thrombopoietin - at last [news; comment]. Nature, 369, 519.
30. MORROW, B. AND KUCHERLAPATI, R. (1993). Gene targeting in mammalian cells by homologous recombination. Current Opinions in Biotechnology, 4, 577.
31. MUCENSKI, M.L., MCLAIN, K., KIER, A.B., SWERDLOW, S.H., SCHREINER, C.M., MILLER, T.A., PIETRYGA, D.W., SCOTT, W.J. JR & POTTER, S.S. (1991). A functional c-Myb gene is required for normal murine fetal hepatic hematopoiesis. Cell, 65, 677.
32. NAKAYAMA, K., YAMAMOTO, R., ISHII, S. & NAKAUCHI, H. (1993). Binding of c-Myb to the core sequence of the CD4 promoter. International Immunology, 5, 817.
33. NESS, S.A., MARKNELL, A. & GRAF, T. (1989). The v-Myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell, 59, 1115.
34. NESS, S.A., KOWENZ-LEUTZ, E., CASINI, T, GRAF, T & LEUTZ, A (1993). Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types. Genes and Development, 7, 749.
35. NOMURA, N., ZU, Y.L., MAEKAWA, T., TABATA, S, AKIYAMA, T. & ISHII, S. (1993a). Isolation and characterization of a novel member of the gene family encoding the cAMP response element-binding protein CRE-BP1. Journal of Biological Chemistry, 268, 4259.
36. NOMURA, T., SAKAI, N., SARAI, A., SUDO, T., KANEI-ISHII, C., RAMSAY, R.G., FAVIER, D., GONDA, T.J. & ISHII, S. (1993b). Negative autoregulation of c-Myb activity by homodimer formation through the leucine zipper. Journal of Biological Chemistry, 268, 21914.
37. OSMAN, F., TOMSETT, B. & STRIKE, P. (1994). Homologous recombination. Progress in Industrial Microbiology, 29, 687.
38. PRESS, R.D., REDDY, E.P & EWERT, D.L. (1994). Overexpression of C-terminally but not N-terminally truncated Myb induces fibrosarcomas: a novel nonhematopoietic target cell for the Myb oncogene. Molecular and Cellular Biology, 14, 2278.
39. PROCHOWNIK, E.V. SMITH, M.J., SNYDER, K & EMEAGWALI, D. (1990). Amplified expression of three jun family members inhibits erythroleukemia differentiation. Blood, 76, 1830.
40. RATAJCZAK, M.Z., HIJIYA, N., CATANI, L., DERIEL, K , LUGER, S.M., MCGLAVE, P & GEWIRTZ, A.M. (1992a). Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-Myb antisense oligodeoxynucleotides. Blood, 79, 1956.
41. RATAJCZAK, M.Z., KANT, J.A., LUGER, S.M., HIJIYA, N., ZHANG, J., ZON, G. & GEWIRTZ, A.M. (1992b). In vivo treatment of human leukemia in a scid mouse model with c-Myb antisense oligodeoxynucleotides. Proceedings of the National Academy of Sciences, USA, 89, 11823.
42. RATAJCZAK, M.Z., LUGER, S.M., DERIEL, K , ABRAHM, J., CALABRETTA, B. & GEWIRTZ, A.M. (1992c) Role of the KIT protooncogene in normal and malignant human hematopoiesis. Proceedings of the National Academy of Sciences, USA, 89, 1710.
43. RATAJCZAK, M.Z., LUGER, S.M. & GEWIRTZ, A.M. (1992d). The c-kit proto-oncogene in normal and malignant human hematopoiesis. International Journal of Cell Cloning, 10, 205.
44. SAKURA, H , KANEI-ISHII, C , NAGASE, T. NAKAGOSHI, H., GONDA, TJ & ISHII, S (1989). Delineation of three functional domains of the transcriptional activator encoded by the c-Myb protooncogene. Proceedings of the National Academy of Sciences, USA, 86, 5758.
45. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proceedings of the National Academy of Sciences, USA, 91, 459.
46. SPILLER, D.G & TIDD, D M (1995). Nuclear delivery of antisense oligodeoxynucleotides through reversible permeabilization of human leukemia cells with streptolysin O. Antisense Research and Development, 5, 13.
47. SZCZYLIK, C., SKORSKI, T., KU, D.H., NICOLAIDES, N.C., WEN, S.C., RUDNICKA, L., BONATI, A., MALAGUARNERA, L. & CALABRETTA, B. (1993). Regulation of proliferation and cytokine expression of bone marrow fibroblasts: role of c-Myb. Journal of Experimental Medicine, 178, 997.
48. TAKESHITA, K., BOLLEKENS, J.A., HIJIYA, N., RATAJCZAK, M , RUDDLE, F.H. & GEWIRTZ, A M (1993). A homeobox gene of the Antennapedia class is required for human adult erythropoiesis. Proceedings of the National Academy of Sciences, USA, 90, 3535.
49. TRAVALI, S., REISS, K., FERBER, A , PETRALIA, S , MERCER. W E., CALABRETTA, B. & BASERGA, R. (1991). Constitutively expressed c-Myb abrogates the requirement for insulin-like growth factor 1 in 3T3 fibroblasts. Molecular and Cellular Biology, 11, 731.
50. VORBRUEGGEN, G., KALKBRENNER, F., GUEHMANN, S & MOELLING, K. (1994). The Carboxy terminus of human c-Myb protein stimulates activated transcription in trans. Nucleic Acids Research, 22, 2466.
51. WEBER, B.L., WESTIN, E.H. & CLARKE, M.F. (1990). Differentiation of mouse erythroleukemia cells enhanced by alternatively spliced c-Myb mRNA. Science, 249, 1291.
52. WILLNOW, T.E & HERZ, J. (1994). Homologous recombination for gene replacement in mouse cell lines. Methods in Cellular Biology, 43, 305.
53. WITTE, O.N. (1993) Role of the BCR-ABL oncogene in human leukemia: Fifteenth Richard and Hinda Rosenthal Foundation Award Lecture Cancer Research, 53, 485.
54. YU, H., BAUER, B., LIPKE, G.K., PHILLIPS, R.L. & VAN ZANT, G. (1993) Apoptosis and hematopoesis in murine fetal liver. Blood, 81, 373.